Tel Aviv - Delayed Quote ILA

Lineage Cell Therapeutics, Inc. (LCTX.TA)

Compare
217.10
+4.60
+(2.16%)
At close: January 12 at 3:49:21 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue 3.78M
Earnings -3.03M
Q4'23
Q1'24
Q2'24
Q3'24
-6M
-4M
-2M
0
2M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 6367
Avg. Estimate 1.62M1.36M8.25M9.99M
Low Estimate 840k840k7.47M--
High Estimate 3.78M1.89M10.41M25.4M
Year Ago Sales 2.12M1.44M8.95M8.25M
Sales Growth (year/est) -23.46%-5.75%-7.73%20.99%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
LCTX.TA --------
S&P 500 8.59%11.42%13.98%13.43%

Upgrades & Downgrades

Maintains Maxim Group: Buy to Buy 1/10/2025
Maintains D. Boral Capital: Buy to Buy 1/3/2025
Maintains HC Wainwright & Co.: Buy to Buy 12/4/2024
Maintains D. Boral Capital: Buy to Buy 11/20/2024
Initiated D. Boral Capital: Buy 11/18/2024
Initiated Craig-Hallum: Buy 8/20/2024

Related Tickers